Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.

Groshkova T, Metrebian N, Hallam C, Charles V, Martin A, Forzisi L, Lintzeris N, Strang J.

Drug Alcohol Rev. 2013 Nov;32(6):566-73. doi: 10.1111/dar.12062. Epub 2013 Sep 30.

PMID:
24118500
2.

Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).

Metrebian N, Groshkova T, Hellier J, Charles V, Martin A, Forzisi L, Lintzeris N, Zador D, Williams H, Carnwath T, Mayet S, Strang J.

Addiction. 2015 Mar;110(3):479-90. doi: 10.1111/add.12748. Epub 2014 Nov 7.

PMID:
25251885
3.

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.

Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, Williams H, Zador D, Evers R, Groshkova T, Charles V, Martin A, Forzisi L.

Lancet. 2010 May 29;375(9729):1885-95. doi: 10.1016/S0140-6736(10)60349-2.

PMID:
20511018
4.

Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, Stewart D, Welch S.

Addiction. 2000 Nov;95(11):1631-45.

PMID:
11219367
5.
6.

Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.

Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N, Strang J.

Br J Psychiatry. 2013 Nov;203(5):341-9. doi: 10.1192/bjp.bp.112.111583. Epub 2013 Sep 12.

7.
8.

After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.

Bond AJ, Reed KD, Beavan P, Strang J.

Drug Alcohol Rev. 2012 Jun;31(4):492-8. doi: 10.1111/j.1465-3362.2011.00353.x. Epub 2011 Sep 15.

PMID:
21919979
9.

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.

Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT.

BMC Health Serv Res. 2011 Jul 26;11:174. doi: 10.1186/1472-6963-11-174.

10.
11.

A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.

Holland R, Matheson C, Anthony G, Roberts K, Priyardarshi S, Macrae A, Whitelaw E, Appavoo S, Bond C.

Drug Alcohol Rev. 2012 Jun;31(4):483-91. doi: 10.1111/j.1465-3362.2011.00394.x. Epub 2011 Dec 12.

PMID:
22150819
12.

Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.

Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):483-9. doi: 10.1016/j.pnpbp.2010.12.002. Epub 2010 Dec 10.

PMID:
21147192
13.

Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.

McKeganey N, Russell C, Cockayne L.

J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15.

PMID:
22703715
14.

History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.

Oviedo-Joekes E, Marchand K, Guh D, Marsh DC, Brissette S, Krausz M, Anis A, Schechter MT.

Addict Behav. 2011 Jan-Feb;36(1-2):55-60. doi: 10.1016/j.addbeh.2010.08.020. Epub 2010 Sep 19.

PMID:
20855171
15.

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†.

Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, Metrebian N.

Br J Psychiatry. 2015 Jul;207(1):5-14. doi: 10.1192/bjp.bp.114.149195. Review.

16.

Diacetylmorphine versus methadone for the treatment of opioid addiction.

Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT.

N Engl J Med. 2009 Aug 20;361(8):777-86. doi: 10.1056/NEJMoa0810635.

17.
18.

Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.

Oviedo-Joekes E, Sordo L, Guh D, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Addict Behav. 2015 Feb;41:81-6. doi: 10.1016/j.addbeh.2014.10.003. Epub 2014 Oct 7.

19.

Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.

Ayres R, Ingram J, Rees A, Neale J, Beattie A, Telfer M.

Subst Abuse Treat Prev Policy. 2014 Nov 18;9:44. doi: 10.1186/1747-597X-9-44.

20.

Heroin maintenance for chronic heroin-dependent individuals.

Ferri M, Davoli M, Perucci CA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003410. doi: 10.1002/14651858.CD003410.pub4. Review.

PMID:
22161378

Supplemental Content

Support Center